The Global and United States Needle-free Injection Systems Market Report was published by QY Research recently.
Needle-free Injection Systems Market Analysis and Insights
This report focuses on global and United States Needle-free Injection Systems market, also covers the segmentation data of other regions in regional level and county level.
Needle-free Injection Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Needle-free Injection Systems market will be able to gain the upper hand as they use the report as a powerful resource.
For United States market, this report focuses on the Needle-free Injection Systems market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Access full Report Description, Table of Figure, Chart, Free sample, etc. please click
https://us.qyresearch.com/reports/162505/needle-free-injection-systems
Needle-free Injection Systems Market Segment by Type
Reusable Injector
Single-use Injector
Needle-free Injection Systems Market Segment by Application
Vaccine Delivery
Insulin Delivery
Others
The report on the Needle-free Injection Systems market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D’Antonio Consultants International
Lepu Medical
TECHiJET
Key Benefits:
To study and analyze the global Needle-free Injection Systems consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Needle-free Injection Systems market by identifying its various subsegments.
Focuses on the key global Needle-free Injection Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Needle-free Injection Systems with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Needle-free Injection Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Needle-free Injection Systems Competitor Landscape by Company
5 Global Needle-free Injection Systems Market Size by Region
5.1 Global Needle-free Injection Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Needle-free Injection Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Needle-free Injection Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Needle-free Injection Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Needle-free Injection Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Needle-free Injection Systems Sales in Value by Region: 2017-2022
5.3.2 Global Needle-free Injection Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Needle-free Injection Systems Market Size YoY Growth 2017-2028
6.1.2 North America Needle-free Injection Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Needle-free Injection Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Needle-free Injection Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Needle-free Injection Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Needle-free Injection Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Needle-free Injection Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Needle-free Injection Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Needle-free Injection Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Needle-free Injection Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Antares Pharma
7.1.1 Antares Pharma Corporation Information
7.1.2 Antares Pharma Description and Business Overview
7.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Antares Pharma Needle-free Injection Systems Products Offered
7.1.5 Antares Pharma Recent Development
7.2 Endo International plc
7.2.1 Endo International plc Corporation Information
7.2.2 Endo International plc Description and Business Overview
7.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Endo International plc Needle-free Injection Systems Products Offered
7.2.5 Endo International plc Recent Development
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Corporation Information
7.3.2 Inovio Pharmaceuticals Description and Business Overview
7.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Products Offered
7.3.5 Inovio Pharmaceuticals Recent Development
7.4 Injex Pharma
7.4.1 Injex Pharma Corporation Information
7.4.2 Injex Pharma Description and Business Overview
7.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Injex Pharma Needle-free Injection Systems Products Offered
7.4.5 Injex Pharma Recent Development
7.5 National Medical Products Inc (J-Tip)
7.5.1 National Medical Products Inc (J-Tip) Corporation Information
7.5.2 National Medical Products Inc (J-Tip) Description and Business Overview
7.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Products Offered
7.5.5 National Medical Products Inc (J-Tip) Recent Development
7.6 Recipharm
7.6.1 Recipharm Corporation Information
7.6.2 Recipharm Description and Business Overview
7.6.3 Recipharm Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Recipharm Needle-free Injection Systems Products Offered
7.6.5 Recipharm Recent Development
7.7 European Pharma Group (InsuJet)
7.7.1 European Pharma Group (InsuJet) Corporation Information
7.7.2 European Pharma Group (InsuJet) Description and Business Overview
7.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Products Offered
7.7.5 European Pharma Group (InsuJet) Recent Development
7.8 Miracle Medical
7.8.1 Miracle Medical Corporation Information
7.8.2 Miracle Medical Description and Business Overview
7.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Miracle Medical Needle-free Injection Systems Products Offered
7.8.5 Miracle Medical Recent Development
7.9 Medical International Technology (MIT)
7.9.1 Medical International Technology (MIT) Corporation Information
7.9.2 Medical International Technology (MIT) Description and Business Overview
7.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Medical International Technology (MIT) Needle-free Injection Systems Products Offered
7.9.5 Medical International Technology (MIT) Recent Development
7.10 Akra Dermojet
7.10.1 Akra Dermojet Corporation Information
7.10.2 Akra Dermojet Description and Business Overview
7.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Akra Dermojet Needle-free Injection Systems Products Offered
7.10.5 Akra Dermojet Recent Development
7.11 PharmaJet
7.11.1 PharmaJet Corporation Information
7.11.2 PharmaJet Description and Business Overview
7.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.11.4 PharmaJet Needle-free Injection Systems Products Offered
7.11.5 PharmaJet Recent Development
7.12 Portal Instruments
7.12.1 Portal Instruments Corporation Information
7.12.2 Portal Instruments Description and Business Overview
7.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Portal Instruments Products Offered
7.12.5 Portal Instruments Recent Development
7.13 Crossject Medical Technology
7.13.1 Crossject Medical Technology Corporation Information
7.13.2 Crossject Medical Technology Description and Business Overview
7.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Crossject Medical Technology Products Offered
7.13.5 Crossject Medical Technology Recent Development
7.14 MIKA MEDICAL
7.14.1 MIKA MEDICAL Corporation Information
7.14.2 MIKA MEDICAL Description and Business Overview
7.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.14.4 MIKA MEDICAL Products Offered
7.14.5 MIKA MEDICAL Recent Development
7.15 Ferring Pharmaceuticals
7.15.1 Ferring Pharmaceuticals Corporation Information
7.15.2 Ferring Pharmaceuticals Description and Business Overview
7.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Ferring Pharmaceuticals Products Offered
7.15.5 Ferring Pharmaceuticals Recent Development
7.16 D’Antonio Consultants International
7.16.1 D’Antonio Consultants International Corporation Information
7.16.2 D’Antonio Consultants International Description and Business Overview
7.16.3 D’Antonio Consultants International Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.16.4 D’Antonio Consultants International Products Offered
7.16.5 D’Antonio Consultants International Recent Development
7.17 Lepu Medical
7.17.1 Lepu Medical Corporation Information
7.17.2 Lepu Medical Description and Business Overview
7.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Lepu Medical Products Offered
7.17.5 Lepu Medical Recent Development
7.18 TECHiJET
7.18.1 TECHiJET Corporation Information
7.18.2 TECHiJET Description and Business Overview
7.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue and Gross Margin (2017-2022)
7.18.4 TECHiJET Products Offered
7.18.5 TECHiJET Recent Development
For More Information About This Report, Please Enter:
https://us.qyresearch.com/reports/162505/needle-free-injection-systems
Any doubts and questions will be welcome.
About Us:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com